July 11, 2018
Moderna Provides Mid-Year Corporate Update
June 14, 2018
Former Akamai CEO Paul Sagan Joins Moderna’s Board of Directors
November 15, 2017
Moderna Announces First-in-Human Dosing for Phase 1 Study (KEYNOTE-603) of mRNA-4157, a Personalized Cancer Vaccine, for the Treatment of Solid Tumors
October 19, 2017
Moderna Named One of Global Biopharmaceutical Industry’s Top Employers in Science Magazine’s Annual Survey
September 26, 2017
Moderna Announces Publication in Molecular Therapy Characterizing Potent Immune Response Generated by Its mRNA Prophylactic Vaccines
January 09, 2017
Moderna Provides Pipeline and Full-Year Corporate Update
January 04, 2017
Moderna Joins the Human Vaccines Project to Help Advance Fundamental Understanding of the Immune System
January 03, 2017
Moderna to Highlight its mRNA Development Candidate Pipeline at 2017 J.P. Morgan Healthcare Conference
October 27, 2016
Moderna Therapeutics Named the No. 3 Top Employer by Science Magazine
October 06, 2016
Moderna Appoints Annie Seibold Drapeau as Chief Human Resources Officer

Pages